Luteal estradiol pretreatment of poor and normal responders during GnRH antagonist protocol
- Resource Type
- Authors
- Ismail Kaarouch; Aicha Madkour; Omar Sefrioui; Noureddine Louanjli
- Source
- Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 35(12)
- Subject
- Adult
Pregnancy Rate
Endocrinology, Diabetes and Metabolism
Poor responder
medicine.medical_treatment
Oocyte Retrieval
030209 endocrinology & metabolism
Fertilization in Vitro
Luteal phase
Luteal Phase
Chorionic Gonadotropin
Andrology
Gonadotropin-Releasing Hormone
03 medical and health sciences
Follicle
0302 clinical medicine
Endocrinology
Hormone Antagonists
Ovarian Follicle
Ovulation Induction
Pregnancy
Synchronization (computer science)
medicine
Humans
reproductive and urinary physiology
Retrospective Studies
030219 obstetrics & reproductive medicine
In vitro fertilisation
Estradiol
urogenital system
business.industry
GnRH Antagonist
Obstetrics and Gynecology
Retrospective cohort study
Estrogens
Embryo Transfer
female genital diseases and pregnancy complications
Recombinant Proteins
Treatment Outcome
Case-Control Studies
Female
Follicle Stimulating Hormone, Human
business
therapeutics
hormones, hormone substitutes, and hormone antagonists
- Language
- ISSN
- 1473-0766
Luteal estradiol pretreatment (LEP) to IVF protocols designed to improve follicle synchronization and retrieval of mature oocytes. We conducted a retrospective study including women undergoing IVF program who were given a course of 4 mg oral estradiol-17β daily from day 20 of the same cycle until day 1 of their next cycle before starting an antagonist protocol, forming LEP-group but control-group started on day 3 a stimulation without pretreatment. A total is divided into 2 groups (poor (group 1